跳至主要内容
临床试验/NCT02704416
NCT02704416已完成不适用

Ablation in Brugada Syndrome for Prevention of VF - A Randomized, Multi-center Study of Epicardial Ablation in Brugada Syndrome Patients to Prevent Arrhythmia Recurrence

Pacific Rim Electrophysiology Research Institute6 个研究点 分布在 2 个国家目标入组 200 人开始时间: 2016年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
6
主要终点
Freedom of Ventricular Fibrillation/Tachycardia Recurrences

研究概览

简要总结

This trial aims to develop evidence based curative treatment with optimal net benefit for patients with Brugada syndrome.

详细描述

This trial aims to develop evidence based curative treatment with optimal net benefit for patients with Brugada syndrome. Since a recent non-randomized pilot study and scarce case reports documented potential clinical benefit of epicardial ablation of fragmented electrograms in the region of the right ventricular outflow tract, patients in this trial will be randomized to continued implanted cardioverter defibrillator therapy (control arm) or ablation of areas of fragmented electrograms in the right ventricular outflow tract plus continued implanted cardioverter defibrillator therapy (intervention arm). A projected 92 patients in each group will be studied.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The diagnosis of Brugada syndrome is based on 2013 HRS/EHRA/APHRS Consensus document criteria
  • Diagnosed symptomatic BrS with an implanted ICD within the last 5 years
  • Diagnosed symptomatic BrS with an implanted ICD longer than 5 years but has at least 1 appropriate shock within the last 5 years
  • The patient is legally competent, willing and able to undergo the study and signed the informed consent
  • The patient is willing and able to adhere to the follow-up visit protocol

排除标准

  • A patient who does not meet inclusion criteria
  • A patient who has had a previous epicardial ablation
  • A patient who is pregnant (which would exclude an ablation procedure)
  • A patient with a co-morbid condition that possesses undue risk of general anesthesia or epicardial ablation
  • A patient who has a history of radiation therapy on the thorax

结局指标

主要结局

Freedom of Ventricular Fibrillation/Tachycardia Recurrences

时间窗: 3 year followup

Survival from ventricular fibrillation of shocked ventricular arrhythmias causing ICD discharge

次要结局

  • Freedom without drug(3 years)

研究者

发起方
Pacific Rim Electrophysiology Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Koonlawee Nademanee, MD

Principal Investigator

Pacific Rim Electrophysiology Research Institute

研究点 (6)

Loading locations...

相似试验